Previous Close | 0.41 |
1-Year Change | -22.64% |
6-Months Change | -28.2% |
3-Months Change | 5.13% |
Moving Avg (50d) | 0.4122 |
Moving Avg (200d) | 0.4949 |
ESG Rating | - |
Exchange | AMEX |
Market Cap. | 216.6M |
Beta (3-Years) | 2.02 |
Revenue Growth (ttm) | 34.44% |
Net Profit Margin (ttm) | -158.75% |
Return On Assets (ttm) | -20.54% |
EPS (ttm) | -0.09 |
PE Ratio (ttm) | -4.56 |
Dividend Yield | % |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Life Sciences Tools & Services |
Country: | United States |